About GNT

Translating discovery into possibility

General Nutraceutical Technology is a New York-based biotechnology company developing evidence-based interventions for allergic and inflammatory diseases.

Our mission

Improve quality of life—and save lives—through the identification, development, and commercialization of better therapeutics.

01

Founding purpose

Co-founded by Dr. Xiu-Min Li to move promising laboratory discoveries toward real-world use.

02

Internal pipeline

A portfolio of therapeutic programs supported by a network of academic and business affiliates.

03

Research network

Close collaboration with academic researchers in allergic disease, cancer, and infectious disease.

04

Development support

Private-foundation support, academic contracts, and partnerships that advance research and development.

2023 NIH support

Programs backed for translation

R21 · NIAID

IgE-suppressing berberine nanomedicine for peanut and tree-nut allergies

R44 · SBIR Phase II

IgE-suppressing berberine nanomedicine for food allergies

R41 · STTR Phase I

Xanthopurpurin analog for multiple food allergies